Read today's Yahoo news. Currently trading under a dime.
The company's patented MANF technology could provide treatment for a number of neurological diseases including Alzheimer's and Parkinson's.
Seeking Alpha article out after the close.
Today's Yahoo news.
Potential license agreement with Becton Dickinson for its diagnostic test to detect early stage Alzheimer's.
Potential $500,000,000 annual revenues.
Trading under a dime.
Currently the most undervalued micro cap in the market.
Under a nickle.